CA3252691A1 - 1,4-BIS-(2-HYDROXY-BENZYL)-1,4,7-TRIAZACYCLONONANE DERIVATIVES AND SIMILAR COMPOUNDS AS LIGANDS IN IRON (III) COMPLEXES, INTENDED FOR USE AS MRI CONTRAST AGENTS - Google Patents

1,4-BIS-(2-HYDROXY-BENZYL)-1,4,7-TRIAZACYCLONONANE DERIVATIVES AND SIMILAR COMPOUNDS AS LIGANDS IN IRON (III) COMPLEXES, INTENDED FOR USE AS MRI CONTRAST AGENTS

Info

Publication number
CA3252691A1
CA3252691A1 CA3252691A CA3252691A CA3252691A1 CA 3252691 A1 CA3252691 A1 CA 3252691A1 CA 3252691 A CA3252691 A CA 3252691A CA 3252691 A CA3252691 A CA 3252691A CA 3252691 A1 CA3252691 A1 CA 3252691A1
Authority
CA
Canada
Prior art keywords
hydroxy
methylene
methyl
bis
diyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3252691A
Other languages
English (en)
French (fr)
Inventor
Mauro Botta
Lorenzo TEI
Fabio CARNIATO
Zsolt BARANYAI
Mariangela BOCCALON
Original Assignee
Bracco Imaging SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Imaging SpA filed Critical Bracco Imaging SpA
Publication of CA3252691A1 publication Critical patent/CA3252691A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA3252691A 2022-07-28 2023-07-28 1,4-BIS-(2-HYDROXY-BENZYL)-1,4,7-TRIAZACYCLONONANE DERIVATIVES AND SIMILAR COMPOUNDS AS LIGANDS IN IRON (III) COMPLEXES, INTENDED FOR USE AS MRI CONTRAST AGENTS Pending CA3252691A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22187403.5 2022-07-28
EP22187403 2022-07-28
PCT/EP2023/071027 WO2024023314A1 (en) 2022-07-28 2023-07-28 1,4-bis-(2-hydroxy-benzyl)-1,4,7-triazacyclononane derivatives and similar compounds as ligands in iron(iii) complexes for use as mri contrast agents

Publications (1)

Publication Number Publication Date
CA3252691A1 true CA3252691A1 (en) 2024-02-01

Family

ID=82780974

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3252691A Pending CA3252691A1 (en) 2022-07-28 2023-07-28 1,4-BIS-(2-HYDROXY-BENZYL)-1,4,7-TRIAZACYCLONONANE DERIVATIVES AND SIMILAR COMPOUNDS AS LIGANDS IN IRON (III) COMPLEXES, INTENDED FOR USE AS MRI CONTRAST AGENTS

Country Status (10)

Country Link
US (1) US12358880B2 (https=)
EP (1) EP4561995A1 (https=)
JP (1) JP2025524769A (https=)
KR (1) KR20250040575A (https=)
CN (1) CN119343336A (https=)
AU (1) AU2023313342A1 (https=)
CA (1) CA3252691A1 (https=)
IL (1) IL317339A (https=)
MX (1) MX2024015341A (https=)
WO (1) WO2024023314A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025163025A1 (en) 2024-01-31 2025-08-07 Bracco Imaging Spa Pyridophane macrocyclic ligands and fe(iii) complexes thereof
CN119499407B (zh) * 2024-11-25 2026-04-07 中国科学院精密测量科学与技术创新研究院 一种Fe基T7肽靶向脑胶质瘤小分子磁共振造影剂及其制备合成方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7390284B2 (ja) 2017-05-19 2023-12-01 ザ リサーチ ファウンデイション フォー ザ ステイト ユニバーシティー オブ ニューヨーク 鉄（ｉｉｉ）ｍｒｉ造影剤として使用するための化合物
CN112996764B (zh) 2018-11-12 2023-11-21 伯拉考成像股份公司 螯合aazta缀合物及其配合物

Also Published As

Publication number Publication date
IL317339A (en) 2025-01-01
KR20250040575A (ko) 2025-03-24
EP4561995A1 (en) 2025-06-04
JP2025524769A (ja) 2025-08-01
AU2023313342A1 (en) 2024-12-19
US12358880B2 (en) 2025-07-15
CN119343336A (zh) 2025-01-21
US20250163007A1 (en) 2025-05-22
WO2024023314A1 (en) 2024-02-01
MX2024015341A (es) 2025-02-10

Similar Documents

Publication Publication Date Title
RU2073005C1 (ru) Хелатное соединение металла
US11357873B2 (en) Chiral cyclen compounds and their uses
US11021451B2 (en) Contrast agents
DE3855177T2 (de) Makrozyklische tetraaza-verbindungen
US5531978A (en) Aminopolycarboxylic acids and derivatives thereof
CA3252691A1 (en) 1,4-BIS-(2-HYDROXY-BENZYL)-1,4,7-TRIAZACYCLONONANE DERIVATIVES AND SIMILAR COMPOUNDS AS LIGANDS IN IRON (III) COMPLEXES, INTENDED FOR USE AS MRI CONTRAST AGENTS
AU2016368545C1 (en) Dimeric contrast agents
SI8810742A (en) Process for the preparation of the new nitrogen-containing cyclic ligands,metallic complexes formed by these ligands and diagnostic composition containing these complexes.
FI96416C (fi) Heterosykliset kelaatin muodostavat yhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät diagnostiset aineet
Gugliotta et al. AAZTA-based bifunctional chelating agents for the synthesis of multimeric/dendrimeric MRI contrast agents
US20240228524A1 (en) Iron(iii) macrocyclic complexes with mixed hyroxyl pendants as mri contrast agents
WO2025120059A1 (en) Compound for disorders associated with excess and/or accumulation of iron ions
HK40118708A (zh) 作为用於用作mri造影剂的铁(iii)络合物中的配体的1,4-二-(2-羟基-苄基)-1,4,7-三氮杂环壬烷衍生物和类似化合物
US20110021765A1 (en) Fluorinated lanthanide probes for 19f magnetic resonance applications
AU617338B2 (en) Aminopolycarboxylic acids and derivatives thereof
WO2025163025A1 (en) Pyridophane macrocyclic ligands and fe(iii) complexes thereof
Dickins et al. A new chiral lanthanide NMR probe for the determination of the enantiomeric purity of α-hydroxy acids and the absolute configuration of α-amino acids in water
Brücher et al. The Future of Biomedical Imaging: Synthesis and Chemical Properties of the
EP3386953B1 (en) Contrast agents
Barnett et al. Syntheses and fluorescence of salicylaldimine schiff base derivatives of 1, 1′‐di (aminoethylaminocarbonylalkyl)‐2, 2′‐biimidazole
Devi Synthesis of and Complexation Studies with Polyaminopolycarboxylic Acid Crown Ethers
IE71186B1 (en) Aminopolycarboxylic acids and derivatives thereof

Legal Events

Date Code Title Description
A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A00-A101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - PCT

Effective date: 20241107

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20241107

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST TO REGISTER A DOCUMENT RECEIVED

Effective date: 20241107

A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET

Effective date: 20250203

A15 Pct application entered into the national or regional phase

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A15-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: NATIONAL ENTRY REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250203

P18 Priority claim added or amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250203

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REGISTER A DOCUMENT REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250203

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250217

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD

Year of fee payment: 2

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250718

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250718